Table 2. Cytokine levels in the study participants.
| Cytokine (pg/ml) | NG-positive (n=61) | NG-negative(n=61) | P-value | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Detectable | Detectable | ||||||||
| n | (%) | median | (IQR) | n | % | median | (IQR) | ||
| Systemic cytokines | |||||||||
| IL-1β | 61 | (100.00) | 0.77 | (0.38-4.16) | 60 | (98.36) | 0.76 | (0.35-1.46) | 0.243 |
| IL-2 | 57 | (93.44) | 3.05 | (1.61-16.04) | 54 | (88.52) | 3.36 | (2.02-5.35) | 0.750 |
| IL-4 | 40 | (65.57) | 1.88 | (0.82-11.27) | 36 | (59.02) | 3.19 | (1.36-6.13) | 0.185 |
| IL-6 | 56 | (91.80) | 5.85 | (2.82-24.57) | 53 | (86.89) | 4.51 | (2.17-6.65) | 0.028 |
| IL-10 | 18 | (29.51) | 0.46 | (0.18-3.06) | 20 | (32.79) | 0.20 | (0.09-0.66) | 0.052 |
| IL-12p70 | 56 | (91.80) | 0.75 | (0.52-2.001) | 49 | (80.33) | 0.86 | (0.55-2.15) | 0.644 |
| Il-17A | 60 | (98.36) | 0.78 | (0.45-3.92) | 55 | (90.16) | 0.75 | (0.41-1.47) | 0.683 |
| IFN-γ | 46 | (75.41) | 0.60 | (0.42-0.98) | 25 | (40.98) | 0.53 | (0.43-0.79) | 0.576 |
| TNF-α | 25 | (40.98) | 11.89 | (2.67-27.68) | 22 | (36.07) | 1.66 | (0.96-13.13) | 0.012 |
| Genital cytokines | |||||||||
| IL-1β | 60 | (98.36) | 100.34 | (8.33-583.27) | 56 | (91.80) | 43.22 | (1.13-352.64) | 0.230 |
| 1L-2 | 15 | (24.59) | 6.163 | (0.88-14.53) | 24 | (39.34) | 10.067 | (7.98-12.88) | 0.505 |
| 1L-4 | 2 | (3.28) | 2.0985 | (1.23-2.97) | 2 | (3.28) | 20.16 | (19.24-21.08) | 0.121 |
| IL-6 | 41 | (67.21) | 59.891 | (20.69-125.07) | 40 | (65.57) | 87.82 | (42.65-239.66) | 0.081 |
| IL-10 | 35 | (57.38) | 0.418 | (0.20-2.41) | 27 | (44.26) | 2.62 | (1.71-5.85) | 0.001 |
| IL-12p70 | 12 | (19.67) | 0.186 | (0.17-0.20) | 8 | (13.11) | 0.225 | (0.18-5.64) | 0.174 |
| IL-17A | 40 | (65.57) | 2.744 | (0.9-8.00) | 37 | (60.66) | 4.211 | (2.42-13.22) | 0.079 |
| IFN-γ | 26 | (42.62) | 0.728 | (0.28-4.29) | 13 | (21.31) | 28.994 | (0.30-65.45) | 0.173 |
| TNF-α | 40 | (65.57) | 11.37 | (3.03-23.60) | 39 | (63.93) | 25.119 | (15.96-34.60) | 0.001 |